Global Age Related Macular Degeneration Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
- Published Date: 2021-04-23
- Report ID: 104411
- Pages: 110
-
Format:
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
Prudent Markets analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Age Related Macular Degeneration Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Age Related Macular Degeneration Drug Market by Prudent Markets Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Age Related Macular Degeneration Drug Market
Applied Genetic Technologies Corp
Astellas Pharma Inc
Benitec Biopharma Ltd
Biokine Therapeutics Ltd
Crinetics Pharmaceuticals Inc
Critical Pharmaceuticals Ltd
Daiichi Sankyo Company Ltd
Diffusion Pharmaceuticals Inc
Dong-A Socio Holdings Co Ltd
Eleven Biotherapeutics Inc
Elsalys Biotech SAS
Lupin Ltd
M's Science Corp
Mabion SA
MacuCLEAR Inc
...
Major Type of Age Related Macular Degeneration Drug Covered in Prudent Markets report:
Lucentis
Eylea
Avastin
Others
Application Segments Covered in Prudent Markets Market
Clinic
Hospital
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Age Related Macular Degeneration Drug Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Lucentis -Product Introduction and Major Manufacturers
1.1.2 Eylea -Product Introduction and Major Manufacturers
1.1.3 Avastin -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.1.1 China Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.1.2 China Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.2.1 EU Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.2.2 EU Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.3.1 USA Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.3.2 USA Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.4.1 Japan Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.4.2 Japan Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.5.1 India Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.5.2 India Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.6.1 Southeast Asia Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.7.1 South America Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.7.2 South America Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Age Related Macular Degeneration Drug Status and Prospect (2015-2026)
2.8.1 Age Related Macular Degeneration Drug Market Size and Growth Rate (2015-2026)
2.8.2 Age Related Macular Degeneration Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Age Related Macular Degeneration Drug Market Assessment by Segment
3.1 Global Age Related Macular Degeneration Drug Capacity and Growth Rate
3.2 Global Age Related Macular Degeneration Drug Sales by Type
3.3 Global Age Related Macular Degeneration Drug Sales Revenue by Type
3.4 Global Age Related Macular Degeneration Drug Consumption by Application
4 Global Age Related Macular Degeneration Drug Market Assessment by Regions
4.1 Global Age Related Macular Degeneration Drug Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Age Related Macular Degeneration Drug Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Age Related Macular Degeneration Drug Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Age Related Macular Degeneration Drug Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Age Related Macular Degeneration Drug Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Age Related Macular Degeneration Drug Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Age Related Macular Degeneration Drug Sales Market Share of Manufacturers (2019-2020)
6.3 Global Age Related Macular Degeneration Drug Sales Revenue Market Share of Manufacturers (2019-2020)
7 Age Related Macular Degeneration Drug Competitive Analysis
7.1 Applied Genetic Technologies Corp
7.1.1 Applied Genetic Technologies Corp Company Profiles
7.1.2 Applied Genetic Technologies Corp Product Introduction
7.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Astellas Pharma Inc
7.2.1 Astellas Pharma Inc Company Profiles
7.2.2 Astellas Pharma Inc Product Introduction
7.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Benitec Biopharma Ltd
7.3.1 Benitec Biopharma Ltd Company Profiles
7.3.2 Benitec Biopharma Ltd Product Introduction
7.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Biokine Therapeutics Ltd
7.4.1 Biokine Therapeutics Ltd Company Profiles
7.4.2 Biokine Therapeutics Ltd Product Introduction
7.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Crinetics Pharmaceuticals Inc
7.5.1 Crinetics Pharmaceuticals Inc Company Profiles
7.5.2 Crinetics Pharmaceuticals Inc Product Introduction
7.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Critical Pharmaceuticals Ltd
7.6.1 Critical Pharmaceuticals Ltd Company Profiles
7.6.2 Critical Pharmaceuticals Ltd Product Introduction
7.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Daiichi Sankyo Company Ltd
7.7.1 Daiichi Sankyo Company Ltd Company Profiles
7.7.2 Daiichi Sankyo Company Ltd Product Introduction
7.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Diffusion Pharmaceuticals Inc
7.8.1 Diffusion Pharmaceuticals Inc Company Profiles
7.8.2 Diffusion Pharmaceuticals Inc Product Introduction
7.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Dong-A Socio Holdings Co Ltd
7.9.1 Dong-A Socio Holdings Co Ltd Company Profiles
7.9.2 Dong-A Socio Holdings Co Ltd Product Introduction
7.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Eleven Biotherapeutics Inc
7.10.1 Eleven Biotherapeutics Inc Company Profiles
7.10.2 Eleven Biotherapeutics Inc Product Introduction
7.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Elsalys Biotech SAS
7.12 Lupin Ltd
7.13 M's Science Corp
7.14 Mabion SA
7.15 MacuCLEAR Inc
8 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
